Global Human Genetics Market

Global Human Genetics Market size was valued at USD 30.11 Bn. in 2023 and the total revenue is expected to grow at a CAGR of 18.1%, reaching nearly USD 96.50 Bn. in the forecasted period.

Human genetics is the scientific study of genetic material, which includes DNA, RNA, and proteins, and how they play key roles in human traits, diseases, and behavior. This includes the study of genetic variations between individuals and populations, their effects on health and disease susceptibility, and the inheritance patterns of traits from parents to offspring. Human genetic market also enclosed the study of gene expression, epigenetics, and the interplay between genes and the environment. It enclosed various technologies, services, and products related to sequencing, genetic testing, analysis, genetic counseling, also interpretation, and gene therapy. The industry includes a wide range of applications, including personalized medicine, disease diagnosis, drug discovery, development, and forensic science.

The Human Genetics Market is highly potent and is driven by advancements in technology, increasing awareness of genetic diseases, high demand for genetic testing, growing investments, and governmental interest and investment in research and development. Understanding gene structure and organization, gene expression, mutation detection and analysis, linkage analysis, genetic mapping, and physical mapping, among other concepts, can be facilitated by these sectors.

To know about the Research Methodology :- Request Free Sample Report

Human Genetics Market Report Scope:

The Human Genetics Market report provides key insights into the market's performance over the forecast period. It covers several segments, including Solution, Testing Type, Deployment, and End-Users, and also the microanalysis of the trends and factors which significantly influence the market, which caters to the need of stakeholders in the industry. The report is a microanalysis of the global Human Genetics Market, which caters to the needs of stakeholders in the industry. It represents a comprehensive overview of the past and current status of the industry, along with the market size and trends, using language that is simple to comprehend. The report encompasses all aspects of the industry, with a specific study of market leaders, followers, and new entrants.

Human Genetics Market Research Methodology:

The methodology used for the human genetics market research consists of primary and secondary research. The primary research methodology involved interviews with key opinion leaders, industry experts, and stakeholders in the industry. The interviews were conducted to obtain information about market trends, size, share, and growth rate.

The Human Genetics Market report also includes PORTER, PESTEL analysis, and the potential impact of macroeconomic factors and their impact on the market. The report is carved using a bottom-up market sizing approach to calculate the precise market size by considering a macro and micro analysis of all potential customers, revenue, and the current market. In addition, the report draws on secondary research to identify segment specifications and qualitative and quantitative data that contribute to the market's growth. The secondary sources referred to for the research include press releases, company annual reports, government websites, and research papers related to the market.

The report's key highlights include:
1. A comprehensive overview of the parent market and substitute market
2. Analysis of changing Human Genetics market dynamics in the industry, including the impact of COVID and economic factors
3. In-depth Human Genetics market segmentation, including trends and growth analysis based on historical and forecast data
4. Coverage of recent industry trends and developments
5. Competitive landscape analysis, featuring a heat map for emerging players, a market share analysis for major players, and detailed profiles.

Human Genetics Market Dynamics:

Rising Education and Awareness of the Human Genetics Market driving the industry
As Genetic therapies are promising higher success rates and advanced supportive technology gaining public awareness and acceptance. With the efforts of research institutes and local government, the success rate to accept human genetic treatments and therapeutics is increasing positively. WHO launched Genetic awareness program to create awareness and educate people about genetic disorders. Above mentioned factors are increasing awareness about human genetics, which drives the growth of the human genetics market across the world.

Human Genetics: New Era of Medicines
The application of human genetics studies builds ways to advance treatments like personalized and precision medicines. Which leads to a new landscape of pharmacogenomics. This help in personalized treatment for the individual to avoid adverse effects. This leads by shifting the fundamentals from the “one size fit” to “tailored targeted” therapies. Human Genetic study helps epigenetic research unravels more than 140 genetic regions which affect adiposity. which is expected to drive the human genetics market growth.

Computation Biology an Opportunity for the Human Genetics Market
Genetical operations create a large amount of data that needs to get cleaned and curated. For that huge space is received and computation biology is the key solution for this type of big data. With the use of computational biology, an increased number of molecular diagnostics are visible in the past time. Human Genetics Market is expected to witness significant opportunities and growth in the future because of computation biology.

Increasing Advantages of Genetic Testing Boosting the Human Genetics Market
Genetic or hereditary diseases are growing as well as with the increasing number of genetic disorders the awareness about genetic testing is heightened as it provides personalized information about a person’s health, disease risk, and other traits also DNA sample collection is usually simple and non-invasive, and shows quick results.

High-Cost of Testing Affecting the Human Genetics Market
The high cost of genetic testing is a major restrain for the Human Genetics market, genetic testing is a complex process to work on, and received more than 1 test to gain an accurate result. The human genetic test varies between USD 200 to USD 1000 depending upon the difficulty of genetic testing.

Rising directly to customer genetic testing limitations

This type of testing cannot tell definitively whether you will or will not get a particular disease. Results often need to be confirmed with genetic tests administered by a healthcare professional. Also, as testing is done outside of a healthcare clinic, individuals often are not provided with genetic counseling or thorough informed consent as well as the tests look only at a subset of variants within genes, so disease-causing variants can be missed. Which is expected to hamper the test rate of the human genetics market.

Limitations over Human Genetic Analysis

Genetic constraints are features of inheritance systems that slow or prohibit adaptation. Genetic testing can provide only limited information about an inherited condition. The test often can't determine if a person will show symptoms of a disorder, how severe the symptoms will be, or whether the disorder will progress over time.

Human Genetics Market Segment Analysis

By Sequencing Method: Human Genetics Market is segmented in the sequencing method which further segment such as Shotgun sequencing is a laboratory technique used to determine the DNA sequence of an organism's genome. It can enhance the accuracy of existing sequencing data, such as the human reference genome, and can also fill in gaps or correct errors left by DNA sequencing methods. On the other hand, de novo sequencing involves sequencing a new genome where no reference sequence exists for alignment. The first step in obtaining the primary genetic sequence of an organism is de novo sequencing, which is essential for a comprehensive genetic analysis of any organism. This segment of the Human genetics market is expected to boost market growth during the forecast period.

By Application, Human Genetics Market is segmented on the basis of Application. Genetic testing plays a vital role in identifying genetic mutations that increase cancer risk. These tests assist in the early detection and diagnosis of cancer which assists in the selection of appropriate treatment options which are expected to hold the largest share of the human genetics market during the forecast period. In cardiology, genetic testing can help identify inherited genetic mutations that increase the risk of cardiovascular developing fetuses, such as Down syndrome, cystic fibrosis, and sickle cell disease. These tests can help parents and healthcare providers make informed decisions about pregnancy management and the treatment of diseases. These tests can also help diagnose and treat inherited heart conditions. In neurology, genetic testing can aid in the diagnosis and management of hereditary neurological disorders, such as Huntington's disease, muscular dystrophy, and epilepsy.

By Product Type, Human Genetics Market is segmented in the Product type which further segment such as Genetic testing tools include various instruments, reagents, and consumables used to perform genetic tests, such as PCR machines, microarrays, and sequencing platforms. These tools are essential for detecting and analyzing genetic variations, mutations, and biomarkers associated with various diseases and conditions.

Genetic testing software includes bioinformatics and data analysis tools used to analyze genetic data generated from genetic testing tools the software segment is expected to fuel the human genetic market during the forecast period. These software tools help in identifying and interpreting genetic variations and provide valuable insights into disease diagnosis, treatment, and prevention. Laboratory services include genetic testing services provided by diagnostic laboratories and healthcare providers. These services include various types of genetic tests, such as carrier screening, prenatal testing, pharmacogenetic testing, and cancer genetic testing.

By Genetic Testing Type, Human Genetics Market is segmented on the basis of Genetic Testing which is further segmented as follows, Carrier screening involves testing to see if a person “carries” a genetic variation (allele) associated with a specific disease or trait. Diagnostic genetic testing identifies whether an individual has a certain genetic disease. This test detects a specific gene alteration but is often not able to determine disease severity or the age of onset. Predictive genetic testing determines whether an individual has an increased risk for a particular disease. Screening genetic tests are performed on a large segment of the asymptomatic population to determine whether they need more definitive testing to diagnose genetic disease.

Human Genetics Market Competitive Landscape

Key Human Genetics Market players are donating such important roles in the human genetic market and the report provides their partnerships, collaboration, mergers, acquisition, recent developments, and launches.
Illumina It is the leading provider of sequencing services and sells both instruments and reagents for genome sequencing. Has recently announced its revolutionary NovaSeq X series platform, Illumina's products are used in a variety of applications, including diagnostics, cancer research, drug development, and agricultural biotechnology. Illumina controls over 80% of the sequencing market. and expected to dominate the Human Genetics Market during the forecast period.

Thermo Fisher Scientific This Company is a leader in serving science and has a wide range of products used in genomic sequencing market including instruments, reagents, and software. The company announced FDA approval of its Oncomine Dx Target Test, which is the first NGS-based companion diagnostic to aid in therapy selection for patients with RET mutations/fusions in thyroid cancers.

Agilent Technologies is a leader in lab equipment and provides services and consumables that are needed for genomic sequencing, such as DNA kits and enzymes. The company announced a partnership with Mytide Therapeutics with a focus on automation, reliability, and data quality issues across the peptide industry.

QIAGEN is also a leading provider of genomic sequencing services and products to offer a wide range of solutions for genomic sequencing including instruments, reagents, and software. The company recently announced the launch of the QIAstat-Dx Viral Vesicular Panel, a new syndromic test that is designed to combat the global health emergency of monkeypox. The panel tests for six pathogens that produce similar symptoms, including Sars-Cov-2.

BGI Genomics is a leading genomic sequencing company and offers a comprehensive suite of sequencing services and products for genome sequencing, genotyping, and genetic diagnosis. In 2021, BGI Genomics partnered with Natera, a leading ctDNA testing company, to announce their plan to provide the BGI/Natera Signature Assay worldwide.

Human Genetics Market Regional Insights

Due to the advanced healthcare infrastructure, increasing government funding for genetic research, and availability of favorable reimbursement policies, the North American market is currently the largest human genetics market. The market is anticipated to maintain a steady growth rate in the upcoming years. The European human genetics market is considered a mature market, primarily due to factors such as the rising prevalence of genetic disorders, the presence of advanced healthcare infrastructure, and the existence of significant market players, and the market is projected to sustain a moderate growth rate during the forecast period.

The Asia Pacific human genetics market is rapidly expanding, mainly propelled by factors such as the rising incidence of genetic disorders, increasing adoption of direct-to-consumer genetic testing, and the presence of advanced healthcare infrastructure in certain nations. The Human Genetics Market is anticipated to maintain a high growth during the forecast period.

Human Genetics Market Scope: Inquire before buying

Human Genetics Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Human Genetics Market Players

1. Illumina
2. Thermo Fisher Scientific
3. Agilent Technologies
4. QIAGEN
5. BGI Genomics
6. Myriael Genetics
7. SYN Lab Espana
8. Biomarkers Technology
9. Echevarne Laboratories
10. Elab Science
11. NIM Genetics
12. Senior Sistemas Omicos
13. Full Genomics
14. Genin Code
15. Atrys Health
16. Genyca
17. Igenomix
18. Genologica
19. Bode Tecgnology Group Inc

Frequently Asked Questions:

1. Which region has the largest share in Human Genetics Market?
Ans: Asia Pacific region held the highest share in 2023.

2. What is the growth rate of Human Genetics Market?
Ans: The Human Genetics Market is growing at a CAGR of 2.9% during forecasting period 2024-2030.

3. What is scope of the Human Genetics Market report?
Ans: Human Genetics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Human Genetics Market?
Ans: The important key players in the Human Genetics Market are – Denso Corporation, Hanon Systems, Sanden Holding Corporation, Mitsubishi Heavy Industries Ltd, MAHLE GmbH, Valeo SA, Keihin Corporation, Calsonic Kansei Corporation, Samvardhana Motherson Group, Subros Limited, SMAC Auto Air, TransAir Manufacturing, Eberspacher Group, Marelli Corporation.

5. What is the study period of this Market?
Ans: The Human Genetics Market is studied from 2024 to 2030.